NeuroSense Therapeutics Financial Ratios for Analysis 2019-2024 | NRSN

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Income Statement Balance Sheet Cash Flow Stmt Key Financial Ratios

Fifteen years of historical annual and quarterly financial ratios and margins for NeuroSense Therapeutics (NRSN).

Metric Name
Current Ratio
Long-term Debt / Capital
Debt/Equity Ratio
Gross Margin
Operating Margin
EBIT Margin
EBITDA Margin
Pre-Tax Profit Margin
Net Profit Margin
Asset Turnover
Inventory Turnover Ratio
Receiveable Turnover
Days Sales In Receivables
ROE - Return On Equity
Return On Tangible Equity
ROA - Return On Assets
ROI - Return On Investment
Book Value Per Share
Operating Cash Flow Per Share
Free Cash Flow Per Share

Metric Name
Current Ratio
Long-term Debt / Capital
Debt/Equity Ratio
Gross Margin
Operating Margin
EBIT Margin
EBITDA Margin
Pre-Tax Profit Margin
Net Profit Margin
Asset Turnover
Inventory Turnover Ratio
Receiveable Turnover
Days Sales In Receivables
ROE - Return On Equity
Return On Tangible Equity
ROA - Return On Assets
ROI - Return On Investment
Book Value Per Share
Operating Cash Flow Per Share
Free Cash Flow Per Share

2024-03-31	2023-12-31	2023-03-31	2022-03-31	2021-12-31	2021-03-31	2020-12-31	2019-12-31
0.26	-	2.80	11.42	-	-	-	-
-0.01	-	0.04	0.02	-	-	-	-
-0.01	-	0.04	0.02	-	-	-	-
-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-
77.28	-	-101.21	-22.43	-	-	-	-
77.28	-	-101.21	-22.43	-	-	-	-
-373.72	-	-54.81	-18.91	-	-	-	-
77.89	-	-96.98	-22.05	-	-	-	-
-0.45	-	-	-	-	-	-	-
0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
-	-	-	-	-	-	-	-